GSA Capital Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $977K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $279K | Sell |
|
|||||
|
2024
Q2 | $1.15M | Sell |
|
|||||
|
2024
Q1 | $1.86M | Sell |
|
|||||
|
2023
Q4 | $2.97M | Buy |
|
|||||
|
2023
Q3 | $1.1M | Buy |
|
|||||
|
2023
Q2 | $103K | Sell |
|
|||||
|
2023
Q1 | $127K | Sell |
|
|||||
|
2022
Q4 | $1.46M | Buy |
|
|||||
|
2022
Q3 | $190K | Buy |
|
|||||
|
2022
Q2 | $154K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $142K | Sell |
|
|||||
|
2021
Q3 | $406K | Sell |
|
|||||
|
2021
Q2 | $1.5M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $496K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $959K | Sell |
|
|||||
|
2018
Q2 | $810K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $850K | Sell |
|
|||||
|
2017
Q3 | $1.45M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $308K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $367K | Sell |
|
|||||
|
2015
Q4 | $597K | Sell |
|
|||||
|
2015
Q3 | $496K | Sell |
|
|||||
|
2015
Q2 | $1.47M | Sell |
|
|||||
|
2015
Q1 | $1.37M | Buy |
|
|||||
|
2014
Q4 | $619K | Sell |
|
|||||
|
2014
Q3 | $741K | Buy |
|
|||||
|
2014
Q2 | $293K | Buy |
|